# Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure

Study · id `cardio:ct-nct03016325` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03016325](<https://clinicaltrials.gov/study/NCT03016325>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03016325

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 329 participants.

## Technical summary

Registry record NCT03016325. Randomized; quadruple masking; primary purpose treatment. Start 2017-01-13 (actual); primary completion 2019-06-23 (actual). Results posted on 2020-08-19.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 329 participants (enrolled count; ClinicalTrials.gov record NCT03016325, source copy `cardio:ctgov-nct03016325-2021-01-06`, retrieved 2026-10-26)
- Started: 2017-01-13 (actual) (ClinicalTrials.gov record NCT03016325, source copy `cardio:ctgov-nct03016325-2021-01-06`, retrieved 2026-10-26)
- Primary completion: 2019-06-23 (actual) (ClinicalTrials.gov record NCT03016325, source copy `cardio:ctgov-nct03016325-2021-01-06`, retrieved 2026-10-26)
- Completion: 2019-11-12 (actual) (ClinicalTrials.gov record NCT03016325, source copy `cardio:ctgov-nct03016325-2021-01-06`, retrieved 2026-10-26)
- Results first posted: 2020-08-19 (ClinicalTrials.gov record NCT03016325, source copy `cardio:ctgov-nct03016325-2021-01-06`, retrieved 2026-10-26)
- Countries: United States; Argentina; Canada; Czechia; France; Germany; Greece; Italy; Japan; Netherlands; Poland; Spain; United Kingdom (ClinicalTrials.gov record NCT03016325, source copy `cardio:ctgov-nct03016325-2021-01-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03016325-2021-01-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure
- Acronym: STANDUP AHF
- Condition: Heart Failure
- Intervention (Drug): HNO Donor
- Intervention (Drug): Placebo
- Lead sponsor: Bristol-Myers Squibb
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Bristol-Myers Squibb (`cardio:org-bristol-myers-squibb`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study (`cardio:pubmed-33248986`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: fbde69ebdb3cea1151f68fcbfab9f3ea74c07016ef8b2ffece4c0655555239df
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
